HK Stock MarketDetailed Quotes

02361 SINOHEALTH HLDG

Watchlist
  • 5.370
  • +0.010+0.19%
Market Closed Apr 26 16:08 CST
2.43BMarket Cap21.57P/E (TTM)

SINOHEALTH HLDG Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
(FY)Dec 31, 2020
(Q9)Sep 30, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
Turnover
11.08%396.19M
19.59%144.95M
10.03%356.67M
--121.21M
60.42%324.17M
66.32%240.43M
13.68%202.07M
--144.56M
8.13%177.75M
--164.39M
Operating income
11.08%396.19M
19.59%144.95M
10.03%356.67M
121.21M
60.42%324.17M
66.32%240.43M
13.68%202.07M
144.56M
8.13%177.75M
164.39M
Cost of sales
12.57%-172.72M
-8.07%-69.77M
-50.20%-197.56M
---64.56M
-83.01%-131.53M
-65.13%-89.84M
-0.30%-71.87M
---54.41M
-13.14%-71.65M
---63.33M
Operating expenses
12.57%-172.72M
-8.07%-69.77M
-50.20%-197.56M
-64.56M
-83.01%-131.53M
-65.13%-89.84M
-0.30%-71.87M
-54.41M
-13.14%-71.65M
-63.33M
Gross profit
40.45%223.47M
32.71%75.18M
-17.41%159.11M
56.65M
47.95%192.64M
67.03%150.59M
22.72%130.21M
90.15M
4.99%106.1M
101.06M
Selling expenses
-2.37%-32.41M
-0.09%-15.11M
-27.74%-31.66M
---15.1M
-67.10%-24.79M
-81.49%-17.34M
-38.74%-14.83M
---9.55M
-38.63%-10.69M
---7.71M
Administrative expenses
24.87%-34.64M
19.25%-15.12M
-4.41%-46.11M
---18.73M
-166.28%-44.16M
-170.03%-31.33M
-29.77%-16.59M
---11.6M
-1.39%-12.78M
---12.61M
Research and development expenses
-1.12%-61.09M
4.53%-27.23M
-12.48%-60.41M
---28.52M
-34.88%-53.71M
-31.63%-38.38M
-36.08%-39.82M
---29.16M
-32.92%-29.26M
---22.01M
Impairment and provision
-799.14%-24.08M
-425.07%-5.36M
6.20%-2.68M
---1.02M
-313.17%-2.86M
-79.53%-1.61M
46.97%-691K
---899K
-342.64%-1.3M
--537K
-Other impairment is provision
-799.14%-24.08M
-425.07%-5.36M
6.20%-2.68M
---1.02M
-313.17%-2.86M
-79.53%-1.61M
46.97%-691K
---899K
-342.64%-1.3M
--537K
Operating interest expense
----
----
----
----
56.46%-532K
54.87%-412K
-112.15%-1.22M
---913K
-9.71%-576K
---525K
Special items of operating profit
9.53%40.13M
230.00%35.81M
24.82%36.64M
--10.85M
54.34%29.35M
62.29%20.63M
21.67%19.02M
--12.71M
4.84%15.63M
--14.91M
Operating profit
102.93%111.38M
1,063.53%48.17M
-42.79%54.89M
4.14M
26.12%95.95M
61.89%82.14M
13.35%76.07M
50.74M
-8.87%67.12M
73.65M
Financing cost
-55.34%-640K
-29.91%-278K
---412K
---214K
----
----
----
----
----
----
Share of profits of associates
----
----
----
----
---416K
---262K
----
----
----
----
Earning before tax
103.29%110.74M
1,119.87%47.89M
-42.98%54.47M
3.93M
25.58%95.53M
61.37%81.88M
13.35%76.07M
50.74M
-8.87%67.12M
73.65M
Tax
-3,655.17%-9.8M
-167.74%-922K
98.89%-261K
--1.36M
-119.22%-23.55M
-187.80%-20.43M
15.65%-10.74M
---7.1M
-1.55%-12.74M
---12.54M
After-tax profit from continuing operations
86.19%100.94M
788.41%46.97M
-24.68%54.21M
5.29M
10.18%71.98M
40.81%61.45M
20.14%65.33M
43.64M
-11.01%54.38M
61.11M
Earning after tax
86.19%100.94M
788.41%46.97M
-24.68%54.21M
5.29M
10.18%71.98M
40.81%61.45M
20.14%65.33M
43.64M
-11.01%54.38M
61.11M
Minority profit
29.32%-1.09M
-160.48%-863K
77.40%-1.55M
--1.43M
-163.19%-6.84M
-130.77%-5.84M
-51.87%-2.6M
---2.53M
-12.57%-1.71M
---1.52M
Profit attributable to shareholders
82.99%102.03M
1,139.20%47.83M
-29.25%55.76M
3.86M
16.03%78.81M
45.74%67.3M
21.10%67.93M
46.17M
-10.44%56.09M
62.63M
Basic earnings per share
76.29%0.2394
1,000.00%0.11
-35.70%0.1358
0.01
0.2112
27.02
Diluted earnings per share
76.29%0.2394
1,000.00%0.11
-35.70%0.1358
0.01
0.2112
27.02
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
Ernst & Young
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021(FY)Dec 31, 2020(Q9)Sep 30, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018
Turnover 11.08%396.19M19.59%144.95M10.03%356.67M--121.21M60.42%324.17M66.32%240.43M13.68%202.07M--144.56M8.13%177.75M--164.39M
Operating income 11.08%396.19M19.59%144.95M10.03%356.67M121.21M60.42%324.17M66.32%240.43M13.68%202.07M144.56M8.13%177.75M164.39M
Cost of sales 12.57%-172.72M-8.07%-69.77M-50.20%-197.56M---64.56M-83.01%-131.53M-65.13%-89.84M-0.30%-71.87M---54.41M-13.14%-71.65M---63.33M
Operating expenses 12.57%-172.72M-8.07%-69.77M-50.20%-197.56M-64.56M-83.01%-131.53M-65.13%-89.84M-0.30%-71.87M-54.41M-13.14%-71.65M-63.33M
Gross profit 40.45%223.47M32.71%75.18M-17.41%159.11M56.65M47.95%192.64M67.03%150.59M22.72%130.21M90.15M4.99%106.1M101.06M
Selling expenses -2.37%-32.41M-0.09%-15.11M-27.74%-31.66M---15.1M-67.10%-24.79M-81.49%-17.34M-38.74%-14.83M---9.55M-38.63%-10.69M---7.71M
Administrative expenses 24.87%-34.64M19.25%-15.12M-4.41%-46.11M---18.73M-166.28%-44.16M-170.03%-31.33M-29.77%-16.59M---11.6M-1.39%-12.78M---12.61M
Research and development expenses -1.12%-61.09M4.53%-27.23M-12.48%-60.41M---28.52M-34.88%-53.71M-31.63%-38.38M-36.08%-39.82M---29.16M-32.92%-29.26M---22.01M
Impairment and provision -799.14%-24.08M-425.07%-5.36M6.20%-2.68M---1.02M-313.17%-2.86M-79.53%-1.61M46.97%-691K---899K-342.64%-1.3M--537K
-Other impairment is provision -799.14%-24.08M-425.07%-5.36M6.20%-2.68M---1.02M-313.17%-2.86M-79.53%-1.61M46.97%-691K---899K-342.64%-1.3M--537K
Operating interest expense ----------------56.46%-532K54.87%-412K-112.15%-1.22M---913K-9.71%-576K---525K
Special items of operating profit 9.53%40.13M230.00%35.81M24.82%36.64M--10.85M54.34%29.35M62.29%20.63M21.67%19.02M--12.71M4.84%15.63M--14.91M
Operating profit 102.93%111.38M1,063.53%48.17M-42.79%54.89M4.14M26.12%95.95M61.89%82.14M13.35%76.07M50.74M-8.87%67.12M73.65M
Financing cost -55.34%-640K-29.91%-278K---412K---214K------------------------
Share of profits of associates -------------------416K---262K----------------
Earning before tax 103.29%110.74M1,119.87%47.89M-42.98%54.47M3.93M25.58%95.53M61.37%81.88M13.35%76.07M50.74M-8.87%67.12M73.65M
Tax -3,655.17%-9.8M-167.74%-922K98.89%-261K--1.36M-119.22%-23.55M-187.80%-20.43M15.65%-10.74M---7.1M-1.55%-12.74M---12.54M
After-tax profit from continuing operations 86.19%100.94M788.41%46.97M-24.68%54.21M5.29M10.18%71.98M40.81%61.45M20.14%65.33M43.64M-11.01%54.38M61.11M
Earning after tax 86.19%100.94M788.41%46.97M-24.68%54.21M5.29M10.18%71.98M40.81%61.45M20.14%65.33M43.64M-11.01%54.38M61.11M
Minority profit 29.32%-1.09M-160.48%-863K77.40%-1.55M--1.43M-163.19%-6.84M-130.77%-5.84M-51.87%-2.6M---2.53M-12.57%-1.71M---1.52M
Profit attributable to shareholders 82.99%102.03M1,139.20%47.83M-29.25%55.76M3.86M16.03%78.81M45.74%67.3M21.10%67.93M46.17M-10.44%56.09M62.63M
Basic earnings per share 76.29%0.23941,000.00%0.11-35.70%0.13580.010.211227.02
Diluted earnings per share 76.29%0.23941,000.00%0.11-35.70%0.13580.010.211227.02
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg